Slower Gastric Emptying: By slowing the movement of food through the stomach, it enhances the feeling of fullness, reducing overall calorie consumption
Its continued prominence is supported by clinical guidelines recommending early metformin use for high-risk individuals and growing physician preference for proven, cost-effective treatments
The TRIUMPH clinical trial program is evaluating retatrutide for multiple indications beyond simple weight loss, including obesity with osteoarthritis, obesity with metabolic complications, type 2 diabetes, cardiovascular outcomes, obstructive sleep apnea, and metabolic dysfunction-associated steatohepatitis
Rosenstock J, Hanefeld M, Shamanna P, Min KW, Boka G, Miossec P, et al
Research suggests weight regain is common when GLP-1 medications are discontinued